JEANETTA MALONE: Open Payments
NPI 1558948547 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 22 payments from 10 companies in 2025. Trend: 2023 $482 · 2024 $1,155 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| ABBVIE INC. | 4 | $75 |
| Alkermes, Inc. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Corium, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, VRAYLAR, REXULTI, ARISTADA, Auvelity, ABILIFY ASIMTUFII, INGREZZA, SPRAVATO.
Industry payments across AL — which companies pay providers there.
